BAJAJ BROKING
Suven Pharma acquires a 56% stake in NJ Bio for ₹535 crore. The deal expands its addressable market from ₹1,600 crore to ₹11,600 crore.
Suven Pharmaceuticals Limited has acquired a 56% controlling stake in NJ Bio Inc, a US-based CRDMO specialising in antibody-drug conjugates (ADC) and emerging modalities. The ₹535 crore deal bolsters Suven’s position in the global ADC market, currently valued at $2.7 billion (approx ₹22,815 crore), with a projected annual growth rate exceeding 25%. This acquisition marks a strategic move to expand Suven’s addressable market from ₹1,600 crore to ₹11,600 crore.
Also read: Paytm Singapore to Sell SARs in PayPay for ₹2,364 Crore
Investment Value: ₹535 crore for a 56% stake in NJ Bio.
Market Growth: ADC outsourcing market valued at ₹22,815 crore, growing at 25% annually.
Capacity Expansion: ₹124 crore allocated for NJ Bio’s Princeton facility expansion.
Also read: Welspun Corp Secures ₹1,300 Crore US Orders for Coated HSAW Pipes
NJ Bio, headquartered in Princeton, New Jersey, has served over 150 clients, completing more than 500 projects since inception. Its projected 2024 revenue stands at $32 million (approx ₹270 crore), reflecting a 70% CAGR since 2021. The deal includes ₹411 crore for acquiring shares from minority stakeholders and ₹124 crore in primary equity, earmarked for enhancing NJ Bio’s 80,000-square-foot facility.
Key Metrics | Value |
Acquisition Cost | ₹535 crore |
NJ Bio’s 2024 Revenue | ₹270 crore |
ADC Market Size | ₹22,815 crore |
ADC Market Growth Rate | 25% annually |
Addressable Market Expansion | ₹1,600 crore to ₹11,600 crore |
The acquisition aligns with Suven Pharma’s growth strategy, enhancing its capabilities in advanced drug modalities. The deal provides Suven access to NJ Bio’s expertise in ADCs, a high-growth segment, and positions it as a major player in the global CRDMO space.
Suven Pharma’s acquisition of NJ Bio marks a significant milestone in its expansion strategy. The ₹535 crore investment not only increases its global footprint but also significantly enhances its market potential. This move could positively influence the Suven Pharma share price, reflecting investor confidence in its growth trajectory.
Also read: Larsen & Toubro Triumphs in ₹702 Crore Tribunal Case, Customs Demand Quashed
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Gold Rate Today | 15 January 2025 | Gold Price in India
15 Jan, 2025 | 40 Min. read
Delhi Court Discharges JSW Steel in Corruption Case; HC Clears Monnet Takeover
15 Jan, 2025 | 2 Min. read
IRFC Emerges L1 Bidder to Finance ₹3,167 Crore for Banhardih Coal Block
15 Jan, 2025 | 2 Min. read
Cipla’s Tax Demand Reduced to ₹559.18 Crores After Revision
15 Jan, 2025 | 2 Min. read
Govt Plans 5-6% Hike in Highway Budget for FY26 After FY25 Slump
15 Jan, 2025 | 2 Min. read
Rikhav Securities IPO- Key Objective & Deep Analysis
15 Jan, 2025 | 5 Min. read
Landmark Immigration IPO- Key Objective & Deep Analysis
15 Jan, 2025 | 5 Min. read
HCL Tech expands partnership with Microsoft to transform contact centres
14 Jan, 2025 | 2 Min. read
BEL secures new orders worth Rs 561 crore, boosting FY25 order book
14 Jan, 2025 | 2 Min. read
ITI Ltd secures Rs 64 crore contracts for Wi-Fi and CCTV systems
14 Jan, 2025 | 2 Min. read
JSW Energy secures LoI for 3.6 GW KSK Mahanadi power plant
14 Jan, 2025 | 2 Min. read
Biocon Biologics’ Johor Bahru Facility Receives FDA VAI Classification
13 Jan, 2025 | 2 Min. read
RBI Launches ULI: Transforming Loan Access
August 27, 2024 | 4 Min. read
Textile Sector in India
September 20, 2024 | 5 Min. read
List of IPOs with DRHPs Filed
November 30, 2023 | 3 Min. read
Aditya Birla Group
September 28, 2023 | 10 Min. read
Bajaj Housing Finance Ltd IPO: Things Smart Investors Need to Know
September 05, 2024 | 4 Min. read
Budget Stock Ideas 2024-2025 | Stocks to Buy Today
July 24, 2024 | 4 Min. read
IPO Eligibility Criteria : Full Details
March 15, 2024 | 6 Min. read
What Is the Lock-In Period in IPOs?
October 18, 2023 | 6 Min. read
Godfrey Phillips Announces 2:1 Bonus Shares
September 16, 2024 | 7 Min. read
Jindal Group- A Comprehensive Analysis
September 27, 2024 | 7 Min. read
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading